Endpoints quoted in trial document(s) (ClinicalTrials.gov, FDA/EMA document, manufacturer's website, published design paper)a	Endpoints quoted in publication(s)b,c	Endpoints quoted in abstract of publication(s)b,c
Gómez‐García 2006	Source: N/T	Primary outcome measure(s): ‐	Primary outcome measure(s): ‐
		Secondary outcome measure(s): ‐	Secondary outcome measure(s): ‐
		Other outcome measure(s): Insulin sensitivity, leptin levels, biochemical profile and androgens	Other outcome measure(s): Insulin sensitivity, leptin levels, biochemical profile and androgens
Marreiro 2006	Source: N/T	Primary outcome measure(s): ‐	Primary outcome measure(s): ‐
		Secondary outcome measure(s): ‐	Secondary outcome measure(s): ‐
		Other outcome measure(s): BMI, fasting glucose and zinc concentration in plasma, insulin, HOMA‐IR, leptin, waist circumference, waist‐to‐hip ratio, percentage of fat	Other outcome measure(s): BMI, fasting glucose, zinc concentration in plasma, urine and erythrocytes, insulin, HOMA‐IR, leptin, glucose
Soheilykhah 2012	Source: N/T	Primary outcome measure(s): ‐	Primary outcome measure(s): ‐
		Secondary outcome measure(s): ‐	Secondary outcome measure(s): ‐
		Other outcome measure(s): Adiponectin, fasting blood glucose, insulin and insulin resistance and lipid profile	Other outcome measure(s): Adiponectin, fasting blood glucose, insulin and insulin resistance and lipid profile
‐ denotes not reported aTrial document(s) refers to all available information from published design papers and sources other than regular publications (e.g. FDA/EMA documents, manufacturer's websites, trial registers). bPublication(s) refers to trial information published in scientific journals (primary reference, duplicate publications, companion documents or multiple reports of a primary study). cOther outcome measures refer to all outcomes not specified as primary or secondary outcome measures. BMI: body mass index; EMA: European Medicines Agency; FDA: Food and Drug Administration (US); HOMA‐IR: Homeostasis Model Assessment of Insulin Resistance; N/A: not applicable; N/T: no trial document available